Thrombopoietin (TPO) regulates megakaryocytic (MK) maturation and platelet production. Molecular and cellular mechanisms of the TPO-induced MK differentiation are not totally understood. In order to develop cellular models to study these mechanisms, we introduced c-mpl into UT-7 and TF-1 cells by means of a retroviral vector and compared the effects of TPO on these two cell lines. UT-7 and TF-1 cell lines are two factordependent leukemic cell lines with an erythroid and MK phenotype. They proliferate in response to IL-3, GM-CSF and EPO, but not to TPO. The erythroid differentiation of both cell lines can be markedly increased by EPO. Several UT-7/c-mpl and TF-1/c-mpl cell clones which express different levels of the c-mpl protein (Mpl) were obtained and all became TPO-dependent for their proliferation. The UT-7/c-mpl clones, but not the TF-1/cmpl clones, were capable of undergoing MK differentiation in response to TPO. This was demonstrated by the increase in MK markers (GPIIb, GPIIIa, GPIb␣, GPIX and vWF), the appearance of cytoplasmic ␣-granules, intracellular membranes resembling demarcation membranes which were immunologically labeled with an GPIIb/IIIa anti-antibody, and a small percentage of polyploid cells (8N and 16N) . In contrast, TPO inhibited the erythroid program of differentiation (glycophorin A, ␤-globin and EPO receptor) as well as the differentiative activity of EPO in both UT-7/c-mpl and TF-1/c-mpl clones. It is noteworthy that the differentiative effect of EPO in TF-1/c-mpl cells was associated with an increase in GATA-1 transcripts which was totally suppressed by TPO. Overall the effects of TPO are the same as those of phorbol myristate acetate (PMA) which also induces MK differentiation and inhibits erythroid differentiation. These results suggest that: (1) Mpl expression is necessary but not sufficient for induction of MK differentiation; and (2) induction of Mk differentiation and inhibition of erythroid differentiation by TPO involve different signaling pathways; the pathway involved in the inhibition of erythroid differentiation might be related to a downregulation of GATA-1 expression in TF-1 cells.
Introduction
The recent discovery of the ligand of c-mpl (Mpl-L) also termed thrombopoietin (TPO), megapoietin or megakaryocyte growth and development factor (MGDF) [1] [2] [3] [4] has provided new insights into the study of the regulation of the molecular and cellular mechanisms leading to megakaryocytopoiesis and platelet production. Indeed, in vitro and in vivo studies have shown that TPO acts as the major physiological regulator of megakaryocytopoiesis and platelet production. 5 In addition, recent studies have shown that TPO also acts on primitive hematopoietic cells inducing their proliferation and survival. 6, 7 However, it is still unknown whether TPO is respon- sible for initiating the megakaryocytic (MK) program of differentiation from a pluripotent progenitor. The molecular aspect of the induction of differentiation is difficult to study with normal hematopoietic cells as a consequence of the low number of pluripotent or MK progenitors in the bone marrow. Continuous murine and human hematopoietic cell lines have been extensively used as a model system to study the molecular regulation of differentiation. Two factor-dependent cell lines with an erythroid and MK phenotype have been established from bone marrow cells of patients with erythro-(TF-1) 8 or megakaryoblastic (UT-7) 9 leukemias. These two cell lines express low numbers of the c-mpl receptors (Mpl) on their surface. 10 However, it has been described that proliferative response to TPO was not directly correlated to the c-mpl expression 11 and that TPO induced only a delayed proliferation in some cell lines. 12, 13 UT-7 and TF-1 cell lines may be interesting models to study induction of differentiation by growth factors. Indeed, EPO not only induces proliferation in UT-7 cells, but increases their erythroid phenotype.
14 In contrast to UT-7 cells, TF-1 cells only transiently proliferate under EPO stimulation. This low proliferative response to EPO is due to an abnormal EPO receptor (EPO-R). 15 Alternatively, the MK phenotype of both cell lines is enhanced by treatment with PMA in a similar manner as in factor-independent erythro-MK cell lines. 9, [16] [17] [18] [19] [20] [21] However, PMA is a chemical agent and the MK differentiation induced by PMA may involve different mechanisms than physiological one as suggested by Hong et al. 22 To understand these mechanisms better, we introduced the c-mpl cDNA into UT-7 and TF-1 cell lines to render them TPO-dependent and compared the effects of TPO stimulation in several UT-7/c-mpl or TF-1/c-mpl cell clones. We found that all transduced UT-7 and TF-1 cell clones proliferated in response to TPO, and while TPO inhibited the erythroid differentiation of both transduced UT-7 and TF-1 cells, only UT-7/c-mpl cells were induced to differentiate towards megakaryocytopoiesis in response to TPO. Two important differences observed between UT-7/c-mpl and TF-1c-mpl cell clones may explain the difference in the TPO response of these cells. While all the TF-1 cell clones express the same low level of c-mpl at the mRNA and protein level, UT-7 clones expressed a heterogenous level of c-mpl. Furthermore and more importantly, GATA-1 was highly and constitutively expressed in UT-7 cells, while GATA-1 expression was induced by EPO and downregulated by TPO in TF-1 cells.
Materials and methods

Cell culture
The human factor-dependent cell lines, TF-1 and UT-7 cells, were kindly provided by T Kitamura 8 
Cytokines and chemicals
Recombinant human erythropoietin (rhEPO) and rhGM-CSF were generously provided by Cilag (Paris, France), Immunex
Figure 1
Proliferation of parental UT-7 and TF-1 cells and UT-7/c-mpl (clone 11OC1) and TF-1/c-mpl (clone 11.1) cell clones stimulated with GM-CSF (square) or TPO (circle). 5 × 10 3 cells were plated per well in 100 l of medium containing 10% of fetal calf serum (FCS) and optimal concentration of GM-CSF (10 ng/ml) or TPO (10 ng/ml). The 3 H-thymidine incorporation was measured 1, 2, 3 and 4 days after plating.
or Novartis (Rueil Malmaison, France) and were used at a final concentration of 1 U/ml and 2.5 ng/ml, respectively. TPO origin was supernatant of the Cos cell line transfected with the full-length human TPO cDNA (kindly provided by JL Villeval and F Wendling, U362 INSERM, Villejuif, France). Controls were performed with PEG-r-hu-MGDF (10 ng/ml), a generous gift of JL Nichols (Amgen, Thousand Oaks, CA, USA). Stock solutions of the phorbol myristate acetate (PMA; Calbiochem, La Jolla, CA, USA; 2 mol) were made in ethanol and dimethylsulfoxide and stored at −20°C.
Retroviral production and infection
A retroviral vector encoding c-mpl was constructed by inserting a blunted SalI-NotI fragment encoding the human cmpl cDNA into the polylinker site of pBTZenSVNEO vector as previously described. 24 In a second construct, the full-length human c-mpl cDNA was modified by the replacement of the mpl signal peptide by that of murine IL-7 followed by the Flag epitope tag sequence. These retroviral vectors, pBTZen-c-mpl-SVNEO and pBTZen-FLAG-c-mpl-SVNEO, were introduced into the amphotropic packaging cell line GP+envAm 12 by a standard transfection procedure using calcium phosphate precipitation. Individual geneticin-resistant colonies were derived in the presence of 1 mg/ml of geneticin (G418; Gibco, Paisley, UK) and their supernatants were tested for retroviral production on NIH3T3 cells. Cell clones with the highest retroviral production (10 6 c-mpl infectious retroviral particles per ml of supernatant) were selected. The structure of integrated retroviruses and expression were assessed by Northern blot analysis (data not shown).
TF-1 and UT-7 cells were cocultured for 48 h on subconfluent irradiated (10 Gy) Gp-envAm 12-c-mpl cells in the presence of rhGM-CSF. Nonadherent cells were then harvested, washed and cloned in a semi-solid medium containing 1% methylcellulose (Fluka, Saint-Quentin Fallavier, France) in ␣-MEM supplemented with 10% FCS, 2.5 ng/ml rhGM-CSF and 1 mg/ml G418. Individual colonies were picked up 10 days later and expanded in liquid medium in the presence of rhGM-CSF and G418. Mpl expression was assessed by Northern blot and flow cytometric analysis.
Northern blot
Total RNAs were isolated by the guanidium isothiocyanate lysis procedure followed by centrifugation over a cesiumchloride cushion as described previously. 25 Six micrograms total RNA were separated by electrophoresis on agarose-formaldehyde gels and transferred to nylon membranes (Hybond N; Amersham). Membranes were hybridized with fragments of human GpIIb, GPIIIa, ␤-globin, GPA, EPO-R, GATA-1, Ets-1, Fli-1, Spi-1 and NF-E2, actin cDNA was used as standard control. These fragments were labelled with ␣- 
Flow cytometric analysis of antigen expression
Binding experiments
rhu TPO was iodinated by the indirect iodogen method 50 purified by size-exclusion chromatography (SEC) and formulated in PBS. The specific activity of the radiolabeled material was 35 Ci/g protein. UT7/c-mpl cells (10 6 ) were incubated with 1 nM of 125 I-TPO in 100 l of binding buffer for 2 h at 4°C with or without a 100-fold molar excess of unlabeled TPO. The binding buffer consisted of culture medium (MEM) supplemented with 10% FCS and 10 nM HEPES (pH7.4). After incubation, cells were washed four times in PBS. Cell-bound and free radioactivity were measured in a gamma counter. Experiments were made in triplicate.
DNA content analysis
Ploidy was determined by flow cytometric analysis of DNA content using a double-staining technique. UT-7/c-mpl and TF-1/c-mpl were washed free of GM-CSF and grown for 4 days with TPO, in culture medium lacking GM-CSF. Alternatively, cells were incubated in culture medium supplemented with GM-CSF in the presence of 10 ng/ml PMA. Cells (1 to 2 × 10 6 ) were harvested by centrifugation at 150 g for 5 min and fixed in ice-cold 80% ethanol for at least 4 h at −20°C. Cells were washed twice in ice-cold PBS 1% FCS, permeabilized in PBS containing 0.25% of Tween 20 (Sigma) for 5 min on ice and washed twice. Cells were then incubated in 0.1 ml PBS 1% FCS with a 1:100 dilution of a pool of anti-vWF MoAbs for 30 min at 4°C. Cells were washed twice and incubated in 0.1 ml PBS 1% FCS with a 1:100 dilution of FITC-Fab′ 2 sheep anti-mouse IgG (Silenus, Hawthorn, Australia). DNA staining was performed by incubation in PBS containing 50 g/ml of propidium iodide (Sigma) and 100 g/ml of RNAse (Merck, Darmstadt, Germany) for at least 2 h. Cells were analyzed by flow cytometry.
Ultrastructural morphology
Cells were washed twice in Hank's medium at 4°C, fixed in 2.5% of glutaraldehyde in Gey's buffer for 10 min, washed and incubated in diaminobenzidine medium. Cells were then post-fixed with osmium tetroxide, dehydrated and embedded in epon for ultrastructural examination. Ultrathin sections were examined with a Philips CM 10 electron microscope (Philips, Eindoven, The Netherlands) after uranyl acetate and lead citrate staining. Alternatively, cells were fixed in glutaraldehyde (1% in phosphate buffer 0.1 M, pH 7.4 for 1 h and embedded in glycol methacrylate for immune electron microscopy. Thin sections were incubated with a polyclonal anti GPIIb/IIIa antibody followed by immunogold as described previously. 26 
Results
Proliferation of UT-7/c-mpl and TF-1/c-mpl cells in the presence of TPO
UT-7 and TF-1 cells infected by coculture with the NEO or cmpl virus producer cells were cloned in methylcellulose in
Figure 2
Expression of GPIIb (TAB) and GPA (CLB) measured by flow cytometry in UT-7 11OC1 and TF-1 11.1 cells. Cells were cultured in GM-CSF, washed three times and stimulated with optimal concentration of EPO, TPO or EPO+TPO for 3 days. Expression of GPIIb and GPA was measured by staining with TAB (GPIIb) and CLB (GPA) monoclonal antibodies. the presence of GM-CSF and G418. Individual clones were picked, amplified and grown either in the presence of GM-CSF or TPO. Parental UT-7 and TF-1, as well as stable c-mpl transfectants, respond equally well to GM-CSF. All stable transfectants tested (13 UT-7/c-mpl and 13 TF-1/c-mpl clones) were able to proliferate in the presence of huTPO while parental UT-7 or TF-1 cells died within 4 days (Figure 1) . TPO or GM-CSF deprivation in the TF-1/c-mpl and UT-7/c-mpl induced cell death in less than 4 days. This result demonstrates that the human Mpl encoded by the viral construct was correctly translocated at the cell surface and transmitted proliferation signal in all G418-resistant UT-7 and TF-1 cells.
Effects of TPO on erythroid and MK markers of differentiation in the UT-7/c-mpl and TF-1/c-mpl cell lines
To assess if UT-7/c-mpl and TF-1/c-mpl cell lines expressing different levels of Mpl were able to undergo MK differentiation in response to TPO, the expression of specific erythroid or MK differentiation markers, was studied by flow cytometry and
Figure 3
Expression of MK and erythroid genes analyzed by Northern blot. Total mRNAs (6 g) from UT-7/c-mpl (clone 110C1) and TF-1/c-mpl (clone 11.1) cells cultured in the presence of GM-CSF (GM) or stimulated with EPO, TPO or EPO+TPO for 3 days, were electrophoresced and hybridized with GPIIb, GPIIIa, ␤-globin, GPA, EPO-R and actin radiolabeled probes. Controls are mRNAs from HEL cells except ␤-globin for which control is mRNAs of human bone marrow cells.
Northern blot analysis. Nuclear polyploidization and the ultrastructural features by electron microscopy, as markers of terminal differentiation, were also studied.
Analysis of erythrocytic and megakaryocytic markers by flow cytometry:
The 11 UT-7/c-mpl and 11 TF-1/c-mpl clones were analyzed by flow cytometry using antibodies directed against erythroid or megakaryocytic markers. Cells were cultured in GM-CSF and switched to TPO for 3 days. All the UT-7/c-mpl and TF-1/c-mpl clones have the same behavior. A representative analysis of the results is shown in Figure 2 . In response to GM-CSF, UT-7/c-mpl cells express low levels of GPIIb and GPIIIa TPO was added to EPO, a decrease in GPA expression was observed (from 39.8 to 13.2 in UT-7/c-mpl and from 27.4 to 4.3 in TF-1/c-mpl). The increase in GPIIb expression of UT-7/c-mpl cells in response to TPO was dose-and time-dependent. Indeed, GPIIb expression was optimal at 10 ng/ml of PEG-r-hu-MGDF, the increase began 12 h after stimulation, was maximal at day 7 and remained constant thereafter (data not shown). The same result was observed for GPIIIa. TPO had only a slight effect on the expression of GPIb␣ (CD42b) and GPIX (CD42a). In addition, TPO induced the expression of vWF which was on the threshold of detection in UT-7/cmpl cultured in the presence of GM-CSF (data not shown). We observed no change in the expression of GPIb␣ (CD42b), GPIX (CD42a) and vWF in TF-1/c-mpl cells in response to TPO.
To test whether the low expression of Mpl at the surface of TF-1/c-mpl cells was responsible for the absence of MK differentiation after TPO stimulation, TF-1/c-mpl cells exhibiting high-level fluorescence staining with anti-Flag antibody (M2; Eastman Kodak, New Haven, CT, USA) were selected and cloned. Flow cytometry analyses with antibodies against GPIIb showed that TPO did not induce MK differentiation in six highly c-mpl-expressing clones (data not shown).
To determine if TPO-induced MK differentiation was reversible, UT-7/c-mpl cells (UT-7 11OC1) were cultured for 3 weeks in the presence of TPO, washed and stimulated with GM-CSF for 7 days. The relative expressions of the MK-specific surface antigen GPIIb and the erythroid-specific antigen GPA were measured. After 3 weeks in the presence of TPO followed by 7 days in GM-CSF, the level of GPIIb expression came back to the same level as in parental UT-7. This demonstrated that the MK differentiation induced by TPO in UT-7/cmpl is reversible (data not shown).
Analysis of erythrocytic and megakaryocytic gene expression by Northern blot:
We then investigated the effects of TPO on MK and erythroid differentiation by analysis of the expression of GPIIb, GPIIIa, GPA, ␤-globin and EPO-R, in one DNA content analysis of TF-1 11.1 and UT-7 110C1 cell clones determined by double staining technique. The cells were cultured in the presence of GM-CSF (GM) or switched in TPO for 3 days. Cells were prepared as described in Materials and methods. The ploidy distribution was determined by setting markers at the nadirs between peaks using the 2 N and 4 N peaks of parental UT-7 cells since UT-7 cells are hyperploid cells.
UT-7/c-mpl (UT-7 11OC1) clone and one TF-1/c-mpl (TF-1 11.1) clone expressing Mpl. By Northern blot, GPIIb transcripts were detected in UT-7/c-mpl and TF-1/c-mpl cells stimulated by GM-CSF (Figure 3) . Accumulation of GPIIb transcripts slightly increased after TPO stimulation in comparison with GM-CSF, while GPIIIa transcript levels were substantially enhanced in UT-7/c-mpl cells. In contrast, no increase in the level of GPIIb and GPIIIa mRNA was observed in TF-1/c-mpl in response to TPO. The level of erythroid specific transcripts (GPA, ␤-globin and EPO receptor) was markedly lower in UT-7/c-mpl and TF-1/c-mpl stimulated by TPO in comparison with cells stimulated by GM-CSF.
It has been shown that TPO and EPO could be synergistic factors on the erythroid and MK differentiation. 27 We studied the effects of their combination on the phenotype of UT-7/cmpl and TF-1/c-mpl cells. EPO increased the surface expression of GPA in both cell lines in comparison with GM-CSF and TPO. The level of GPA transcripts (predominant form 1.7 kb) was also markedly enhanced by EPO, especially in TF-1/c-mpl cells. The same results were found for the ␤-globin and EPO-R mRNAs. When cells were stimulated by the combination of EPO and TPO, phenotypes of the UT-7/c-mpl and TF-1/c-mpl were exactly similar to those of cells grown in TPO alone. Similar results were observed at the level of GPIIb, GPIIIa, GPA, ␤-globin and EPO-R transcripts. Thus, when UT-7/c-mpl cells were stimulated with EPO plus TPO, an increase in MK markers of differentiation and a simultaneous decrease of erythroid differentiation markers were observed. In the same conditions, in TF-1/c-mpl cells TPO completely suppressed the erythroid differentiation induced by EPO without inducing MK differentiation.
Analysis of ploidy:
We then analyzed the effects of TPO on the polyploidization of UT-7 11OC1 and TF-1 11.1 cells. A representative histogram of the ploidy in response to GM-CSF or to TPO is shown in Figure 4 . TPO induced a polyploidization of a minority of UT-7 11OC1 cells. Indeed, some 8N and 16N polyploid cells were present (10-fold over the
Figure 5
Electron microscopy of a UT-7 110C1 cell cultured in the presence of TPO for 3 days. (a) In the Golgi region (Go), numerous granule profiles are present, some of them display dense nucleoid like MK ␣-granules (arrows). (b) Intracellular membranes developed within the cytoplasm (arrows) are more abundant at the cell periphery (N, nucleus; m, mitochondria; pm, plasma membrane; er, endoplasmic reticulum; magnification, × 15 600).
Figure 6
Expression of the retroviral c-mpl gene analyzed by Northern blot in 13 UT-7/c-mpl and TF-1/c-mpl clones. Six micrograms of total mRNA were electrophoresced and hybridized with a NEO probe. mRNA from the two virus producing cells which were used to infect UT-7 and TF-1 cells (GpAm/Mpl5 and GpAm/Mpl11) were also analyzed. Ethidium bromide staining (28S) indicates the amount of mRNA loaded.
basal level, 4% of the cells were у8 N in response to TPO vs 0.41% in response to GM-CSF). Induction of polyploidization by TPO in UT-7 11OC1 cells was maximal at day 7 (0.87% of the cells contained 8 N in response to GM-CSF, 1.72% at day 3 and 3.6% at day 7 in response to TPO, data not shown). Some TF-1 polyploid cells were observed under GM-CSF, but their frequency was not increased by TPO stimulation.
Ultrastructural analyses:
Ultrastructural analyses of UT-7/c-mpl (UT-7 11OC1) cells revealed that TPO induced MK differentiation. Indeed, these cells developed a system of intracellular membranes bearing similarities with demarcation membranes located in the periphery of the cytoplasm ( Figure  5 ). Immunogold labeling for GPIIb IIIa showed that these intracellular membranes were strongly labeled, thus corresponding to channels formed by the invaginated plasma membrane rather than cytoplasmic vacuoles. In the Golgi region, immature granules, some of them exhibiting dense nucleoid-like MK ␣-granules, were present (data not shown). These demarcation membranes and ␣-granules were not observed either in parental UT-7 cells or in GM-CSF-treated UT-7/c-mpl cells.
Mpl expression in infected cells
To evaluate the level of Mpl expression in parental and infected cells, Northern blot, flow cytometric and binding experiments were performed.
Total mRNAs from 13 c-mpl-infected UT-7 and 13 c-mplinfected TF-1 clones were hybridized with a NEO probe ( Figure 6 ). All the different infected TF-1 cells accumulated retroviral c-mpl mRNA at a comparable level which was close to that of the virus producing cells. c-mpl mRNA accumulation was heterogenous in UT-7-infected clones. Some of them expressed c-mpl at a very high level (UT-7 5.1, 11.2, 11OC1, 11OC2), some at an intermediate level (5OC1, 5.3, 11.8 or 11.9) and some at a very low level (11.3, 11.4, 11.5, 11.6 and 11.7). The blots were hybridized with a c-mpl probe and similar results were observed.
To evaluate the cell surface display in transduced cells, flow cytometric analyses were performed in 11 UT-7/c-mpl and 11 TF-1/c-mpl cell clones with the M1 monoclonal antibody which recognizes the hu-Mpl. In 10 out of 11 clones, the labeling was more intense than in the parental cell line. Only one clone (UT-7 5.3) which accumulated an intermediate level of Mpl mRNA (Figure 6 ), expressed a very low level of Mpl at the cell surface. Quantification of the receptor at the cell surface with calibrated microbeads by flow cytometry gave a number of receptors varying from 55 000 to undetectable (Ͻ1000) (data not shown). On the contrary, M1 MoAb detected the same basal level of labeling in parental and infected-TF-1 clones (11 TF-1 cell clones were analyzed). Figure 7 illustrates results obtained with two representative clones.
To demonstrate more firmly these differences in the expression of Mpl between clones, binding experiments with radio-iodinated rhuTPO were performed on representative clones: one TF-1 (TF-1 11.1) and two UT-7 infected clones; one which shows a high level (UT-7 11OC1) and one with a low level (UT-T 5.3) of M1 labeling. UT-7 11OC1 cells combined a much higher specific binding of 125 I-TPO (1200 c.p.m.) than the two other clones (UT-7 5.3, 72 c.p.m.
Figure 7
Expression of Mpl analyzed by cytometry with M1 antibody. Cells from three UT-7 and three TF-1 clones were labeled. Cells were stimulated with GM-CSF. and TF-1 11.1, 69 c.p.m.). Therefore, these binding experiments correlated well with the results obtained with the M1 MoAb and clearly establish that M1 labeling was specific for Mpl, at least in these two cell lines.
Expression of transcription factors
In order to determine if the expression of specific transcription factors was correlated with the induction of megakaryocytic differentiation induced by TPO, the accumulation of different transcriptions factor transcripts (GATA-1, Ets-1, Fli-1, Spi-1, NF-E2) was studied. As shown in Figure 8 , GATA-1 transcript was accumulated at a very high level in UT-7/c-mpl stimulated by GM-CSF, and did not change after 3 days of EPO or TPO stimulation. In contrast, in c-mpl-expressing TF1 cells, GATA-1 mRNA accumulation was important in response to EPO and TPO inhibited the upregulation of GATA-1 transcripts induced by EPO.
The transcription factors of the Ets family, except Spi-1, were poorly expressed in infected-UT7 and TF1 cells and the level of expression did not change in response to EPO or TPO.
More surprisingly, while NF-E2 mRNA accumulation has been described in erythroid and megakaryocytic cells, we did not observe accumulation of NF-E2 transcripts in response to EPO or TPO in UT-7-expressing c-mpl.
The expression of the transcription factors studied was not clearly correlated with the TPO-induced megakaryocytic differentiation.
Discussion
Recently, several groups have investigated the role of the activation of growth factor receptors in the regulation of the pluripotent progenitor determination. There is increasing evidence that MK and erythroid lineages arise from a common bipotent progenitor and that this cell may express EPO-R and Mpl. [28] [29] [30] Therefore, it can be hypothesized that EPO and TPO act competitively on this bipotent progenitor to induce erythroid and MK differentiation. Several cell lines with such bipotent potential have been established from bone marrow cells of patients with erythro-or megakaryoblastic leukemias (TF-1 and UT-7 cells). These cells differentiate towards megakaryopoiesis in response to phorbol ester but do not undergo megakaryocytic differentiation in response to TPO. The proliferative response to TPO of UT-7 and TF-1 remains controversial. While the original cell line does not respond to TPO, Komatsu et al 31 could obtain a subline of UT-7 which is able to grow in response to TPO. It has been shown that TF-1 could survive and grow slowly in the presence of TPO. 12 However, we were unable to grow this cell line with TPO. This result seems to be related to a very low expression of Mpl in the TF-1 cell line.
To obtain a cellular model able to differentiate towards both erythrocytopoiesis and megakaryocytopoiesis in response to EPO or TPO, respectively, c-mpl was transduced into UT-7 and TF-1 cells by means of a retroviral gene transfer.
Our data showed that, after transduction, all the NEO-resistant TF-1 and UT-7 cell clones proliferate in response to TPO.
Figure 8
Analysis of the expression of transcriptional factors by Northern blot in response to TPO. Total mRNA (6 g) from UT-7/c-mpl (clone 110C1) and TF-1/c-mpl (clone 11.1) cells stimulated with GM-CSF, EPO, TPO or EPO+TPO were electrophoresced and hybridized with GATA-1, Ets-1, Fli-1, Spi-1, NF-E2 and actin radiolabeled probes. All the controls are mRNA from HEL cells except for Spi-1 for which the control is mRNA from human bone marrow cells.
TPO suppressed erythroid differentiation in Mpl-expressing UT-7 and TF-1 cells, while it induced megakaryocytic differentiation only in UT-7/c-mpl cells.
Mpl-expressing UT-7 and TF-1 cells proliferate in response to TPO. This result confirms other studies which show that many cytokine receptors are functional and transduce proliferative signal when they are introduced in a large variety of cells. [32] [33] [34] [35] [36] This can be due to the similarity of the proliferative signal induced by GM-CSF, 37 EPO 38 and TPO. 39 The induction of differentiation seems to be more specific of the receptor and of the cells in which it is expressed. For example, the activation of EPO-R induces the expression of the globin gene in cells with erythroid potentialities, 40 but does not modify the expression of differentiation genes (immunoglobulin, GATA-1 or globin genes) in plasmacytoma cells. 36 Interestingly, most UT-7/c-mpl cell clones were able to differentiate towards megakaryocytpoiesis in response to TPO. TPO stimulation increased the expression of MK-specific markers including GPIb, GPIIb, GPIIIa, and vWF in comparison with cells grown in GM-CSF. Induction of differentiation was incomplete as development of demarcation membranes and ␣-granules was limited and only a small fraction of the UT-7/c-mpl polyploidized. Overall, these results are identical to those reported by Porteu et al 41 on UT-7 cells using the same approach and those reported by Komatsu et al 31 who derived a TPO-dependent subline (UT-7/TPO) by selection, although in this subline, MK differentiation may be more complete.
Furthermore, TPO induced the expression of MK markers in UT-7/c-mpl cells, but not in TF-1/c-mpl cells. This was unexpected as these two cell lines have very similar phenotypes. The difference in the response of Mpl-expressing UT-7 and TF-1 cells to the TPO stimulation may be due either to a difference in the Mpl expression at the surface of the cells or to a molecule necessary for the signal transduction which is absent in TF-1 cells.
It seems that the absence of megakaryocytic differentiation of TF-1/c-mpl cells in response to TPO cannot be explained solely by low Mpl expression. Indeed, when highly mplexpressing TF-1 cell clones were selected with an anti-flag antibody, these clones did not differentiate in response to TPO. This result is in accordance with published results 12, 42 showing that TPO induces only a low increase in the expression of megakaryocytic markers in the MO-7E cells which constitutively express a high level of Mpl on their cell surface. Therefore, other downstream molecules may be important to induce differentiation.
Transcription factors or molecules activated after the binding of TPO or EPO to their respective receptor may play a role in this phenomenon. A number of transcription factors are responsible for the expression of the differentiation genes specifically expressed in erythroid and megakaryocytic cells (for review see Ref. 43) . Recently, it has been shown that TPO induces the GPIIb expression by enhancing Spi 1 expression. 44 We did not observe accumulation of GATA-1, Ets-1, Fli-1, Spi-1 or NF-E2 p45 mRNAs during TPO-induced MK differentiation of UT-7/c-mpl cells. These results do not exclude that another member of the Ets family may regulate MK-specific genes in UT-7 cells. In addition, our experiments were only performed at the mRNA level and we cannot exclude that TPO modifies the transcription factors at the protein level or their transcriptional activity by acting on their partners.
An unexpected finding was that TPO suppresses erythroid differentiation in both UT-7/c-mpl and TF-1/c-mpl cells. There is increasing evidence that TPO and EPO have very similar activities during normal differentiation. On one hand, EPO induces MK differentiation in murine MK progenitors and has a synergistic effect with TPO on the growth of MK progenitors; on the other hand, TPO increases erythroid proliferation both in vivo and in vitro and is able to induce differentiation of EPO-R −/− erythroid progenitors. 45 In addition, after ectopic expression of EPO-R or Mpl in pluripotent stem cells, erythroid and MK differentiation are similarly sustained by EPO and TPO. 24, 46 Identical results on the inhibition of erythroid differentiation by TPO in UT-7 cells have been reported by Porteu et al, 41 but they also showed that priming by EPO permitted UT-7 cells to respond better to TPO. This inhibition of erythroid differentiation was also observed in TF-1/c-mpl cells in the absence of the induction of a MK phenotype. This suggests that induction of MK differentiation and suppression of erythroid differentiation follow two different signaling pathways. In both cell lines, suppression of erythroid differentiation was associated with a profound downregulation of the EPO-R, even more pronounced than previously described after GM-CSF stimulation.
14 However, we have previously demonstrated that the inhibition of erythroid differentiation by GM-CSF in UT-7 cells was not due to this EPO-R downregulation. 47 In TF-1/c-mpl cells, the mechanisms of erythroid differentiation inhibition by TPO might be related to GATA-1 expression. In contrast to UT-7 cells, TF-1/c-mpl cells grown under GM-CSF or TPO expressed a low level of GATA-1 transcripts, and EPO-induced erythroid differentiation was associated with a marked increase in GATA-1 and EPO-R transcript levels. Therefore, in TF-1 cells, EPO directly induced the accumulation of GATA-1 transcripts which was followed by the increase of the transcriptional rate of both EPO-R and erythroid specific genes such as ␤-globin or GPA. In contrast, TPO was capable of completely preventing this upregulation of GATA-1 by EPO and to inhibit erythroid differentiation, as GATA-1 is absolutely required for erythroid specific gene expression. 48 This mechanism is not operating in UT-7 cells due to a constitutive high level of GATA-1. It can be speculated that, in UT-7 cells, induction of erythroid differentiation by EPO is not directly related to GATA-1 but to a partner which may be a limiting factor. 49 In this hypothesis, TPO may suppress the EPO-induction of this partner of GATA-1 in UT-7 but does not suppress GATA-1 expression which is indispensable for MK differentiation.
